1. Stocks
    2. /
  2. Clinuvel Pharmaceuticals (ASX: CUV)
    3. /

Clinuvel Pharmaceuticals (ASX: CUV) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Clinuvel Pharmaceuticals Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Clinuvel Pharmaceuticals (ASX: CUV)
    Latest News

    A man holds up a block from falling in a row of dominos.
    Healthcare Shares

    This ASX healthcare stock fell 18% in a month – is it a buy low?

    | Aaron Bell

    Guidance out of Bell Potter suggests this stock is set to rebound. 

    Read more »

    high share price
    Share Gainers

    Why Clinuvel, DroneShield, Nuix, and Telix shares are storming higher today

    | James Mickleboro

    These shares are climbing more than most today. But why?

    Read more »

    Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
    Healthcare Shares

    Why is this ASX healthcare stock jumping 10% on Tuesday?

    | James Mickleboro

    Some good news is giving this stock a big lift on Tuesday.

    Read more »

    a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
    Share Gainers

    Why Clinuvel, CSL, Pro Medicus, and Zip shares are racing higher today

    | James Mickleboro

    These shares are ending the week with a bang. But why?

    Read more »

    Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
    Share Market News

    This ASX 300 stock is up 6% on exciting news

    | James Mickleboro

    This growing company has its eyes on a very large market opportunity.

    Read more »

    A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
    Earnings Results

    This ASX 300 healthcare share just crashed 16%. Here's why

    | Bernd Struben

    Investors are punishing the ASX 300 healthcare company today. But why?

    Read more »

    A man and woman in an office look at a laptop and discuss investing, budget strategies or other financial concepts
    Share Gainers

    Why Clinuvel, Cuscal, EOS, and Zip shares are storming higher today

    | James Mickleboro

    These shares are ending the week with a bang. But why?

    Read more »

    A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
    Broker Notes

    Bell Potter names more of the best ASX shares to buy in August

    | James Mickleboro

    Let's see which shares make the list in August and why the broker is bullish on them.

    Read more »

    a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
    Share Market News

    3 of the best ASX shares to buy with $5,000

    | James Mickleboro

    These shares could be among the best to buy now according to Bell Potter.

    Read more »

    Broker looking at the share price on her laptop with green and red points in the background.
    Healthcare Shares

    These healthcare stocks could be set to double according to broker

    | Aaron Bell

    Interested in gaining exposure to the healthcare sector? These options could be ones to watch. 

    Read more »

    A man clenches his fists in excitement as gold coins fall from the sky.
    Growth Shares

    These ASX growth stocks could rise 80% to 100%

    | James Mickleboro

    Let's see what brokers are tipping as buys with big return potential.

    Read more »

    A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
    Small Cap Shares

    3 of the best small cap ASX stocks to buy now

    | James Mickleboro

    Bell Potter thinks these shares are among the best to buy at the small end of town.

    Read more »

    Frequently Asked Questions

    Yes, Clinuvel Pharmaceuticals has historically paid one unfranked shareholder dividend a year.

    Clinuvel Pharmaceuticals generally pays its shareholder dividend in September.

    Clinuvel Pharmaceuticals does not have a dividend reinvestment plan.

    Clinuvel Pharmaceuticals Limited listed on the ASX on 13 February 2001.

    CUV ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Clinuvel Pharmaceuticals

    Clinuvel Pharmaceuticals Ltd (ASX: CUV) is an Australian-based global biopharmaceutical company developing drugs for the treatment of genetic and vascular disorders. Its principal product SCENESSE is a drug for an inherited disorder, erythropoietic protoporphyria, that causes an intolerance to light.

    Its pioneering work aims at preventing the symptoms of skin diseases related to exposure to UV radiation and at repigmentation of the skin due to depigmentation disorders. Geographically, the company derives the majority of its revenue from its US and European markets.

     

    Profile

    since

    Note